Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

Summary

Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD is a medical facility located in Baltimore, Maryland. This center is recognized for care of Motor Skills, Stroke, Schizophrenia, Lung Cancer, Psychotic Episodes and other specialties. Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD is involved with conducting 200 clinical trials across 275 conditions. There are 19 research doctors associated with this hospital, such as Arif Hussain, MD, Ilias Spanakis, MD, Alice S. Ryan, PhD, and Odessa R. Addison, PhD DPT.

Top PIs

Clinical Trials running at Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

Prostate Cancer

Small Cell Lung Cancer

Motor Skills

Lung Cancer

Post-Traumatic Stress Disorder

I Am A Healthy Volunteer

Cancer

SHOX Deficiency Disorder

Obesity

Post-COVID Syndrome

Shorter vs Usual Radiation Therapy

for Prostate Cancer

This phase III trial compares stereotactic body radiation therapy (SBRT), (five treatments over two weeks using a higher dose per treatment) to usual radiation therapy (20 to 45 treatments over 4 to 9 weeks) for the treatment of high-risk prostate cancer. SBRT uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses over a shorter period of time. This trial is evaluating if shorter duration radiation prevents cancer from coming back as well as the usual radiation treatment.

Recruiting

2 awards

Phase 3

10 criteria

Systemic + Local Therapy

for Prostate Cancer

This is a prospective, open-label, multi-center seamless phase II to phase III randomized clinical trial designed to compare SST with or without PET-directed local therapy in improving the castration-resistant prostate cancer-free survival (CRPC-free survival) for Veterans with oligometastatic prostate cancer. Oligometastasis will be defined as 1-10 sites of metastatic disease based on the clinical determination of the LSI which incorporates all imaging, clinical, and pathologic data available.

Recruiting

1 award

Phase 2 & 3

3 criteria